Iradimed CORP (IRMD) — 10-Q Filings

10-Q Filings (6)

• IRADIMED's Q3 Revenue Jumps 13.5%, Net Income Up 13.8% — Nov 3, 2025 Risk: medium
  IRADIMED CORP (IRMD) reported robust financial performance for the nine months ended September 30, 2025, with revenue increasing by 13.5% to $61,122,101 from $5
• IRADIMED Posts Mixed Q2: US Growth Offsets International Dip — Aug 1, 2025 Risk: medium
  IRADIMED CORP (IRMD) reported a mixed financial performance for the quarter ended June 30, 2025. Revenue from U.S. operations for the three months ended June 30
• IRadimed Corp. Files Q1 2025 10-Q — May 5, 2025 Risk: low
  IRadimed Corp. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 20
• IRadimed Corp. Assets Stable at $126.7M — Oct 31, 2024 Risk: low
  IRadimed Corp. reported total assets of $126.7 million as of September 30, 2024, a slight increase from $126.6 million at the end of fiscal year 2023. The compa
• Iradimed Corp. Files Q2 2024 10-Q — Aug 1, 2024 Risk: low
  Iradimed Corp. reported its Q2 2024 financial results for the period ending June 30, 2024. The company's financial statements show changes in retained earnings
• IRADIMED CORP Files 10-Q for Period Ending March 31, 2024 — May 2, 2024 Risk: low
  IRADIMED CORP (IRMD) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. IRADIMED CORP filed a 10-Q report for the period ending March 31, 2024. The fi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX